Kaizuka City Hospital
Kaizuka, Osaka, Japan
Government hospital in Kaizuka
3 Chome-10-20 Hori, Kaizuka, Osaka 597-0015
About Kaizuka City Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Gynecologic Oncology Trial & Investigation Consortium
1
Japanese Gynecologic Oncology Group
1
Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group
1
Pfizer
1
Clinical Trials at Kaizuka City Hospital
During the past decade, Kaizuka City Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of Aprepitant / Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting (CINV) in Colorectal Cancer Patients - SENRI Trial
2011-04-01
2015-04-01
Completed
413
Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial
2010-05-01
2021-02-28
Completed
655
Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in Japan
2022-04-20
2024-06-30
Active, not recruiting
688
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Kaizuka City Hospital"
#1 collaborator was "Japanese Gynecologic Oncology Group" with 1 trials as a collaborator and "Korean Gynecologic Oncology Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Kaizuka City Hospital
According to Clinical.Site data, the most researched conditions in "Kaizuka City Hospital" are
"Epithelial Ovarian Cancer" (2 trials), "Breast Cancer" (1 trials), "Colorectal Cancer" (1 trials), "Fallopian Tube Cancer" (1 trials) and "Primary Peritoneal Carcinoma" (1 trials). Many other conditions were trialed in "Kaizuka City Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Kaizuka City Hospital
Most popular intervention types in "Kaizuka City Hospital" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Aprepitant / Fosaprepitant" (1 trials), "Endocrine therapy" (1 trials), "Paclitaxel(intravenous) + Carboplatin(intraperitoneal)" (1 trials), "Paclitaxel(intravenous) + Carboplatin(intravenous)" (1 trials) and "Palbociclib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kaizuka City Hospital
The vast majority of trials in "Kaizuka City Hospital" are
2 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Kaizuka City Hospital
Currently, there are NaN active trials in "Kaizuka City Hospital".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Kaizuka City Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kaizuka City Hospital, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".